After outliving Booker T. Bones, their second service dog, Brenda and Brian Marquis still needed help with some of the more difficult parts of daily life.
They found Robbie, a robot that rolls out of a hallway into their living room several times a day.
“Do you want to exercise now? Please answer yes or no,” the caregiver robot asks 59-year-old Brian Marquis, who has been living with a traumatic brain injury since a 2012 car crash.
Are we on the verge of outrunning aging entirely? Renowned futurist and inventor Ray Kurzweil shares his data-driven predictions on the exponential trajectory of artificial intelligence and its near-term impact on human health.
Speaking to a Cosmos conference from his studio, Kurzweil charts the predictable, uninterrupted 80-year history of computing power from early wartime codebreaking machines to modern cloud processors. He explains why the sudden emergence of massive neural networks and \.
Aging involves a decline in physiological functions and increased disease susceptibility, with the immune system playing a pivotal role. Recent research reveals that nonimmune structural cells, such as fibroblasts, epithelial cells, and neurons, develop immune-like properties crucial for stress response and tissue integrity. However, with aging, these organized, nonimmune cells in multicellular organisms gradually lose their identity and organization. They may exhibit unicellular properties, acquire macrophage-like characteristics, or enter a state of senescence, contributing to chronic inflammation.
Deep brain stimulation (DBS) has been used for more than three decades to treat motor symptoms of Parkinson’s disease. Today, more than 200,000 patients worldwide have been implanted with these systems, which continuously deliver electrical stimulation to specific deep-brain regions to reduce rigidity and tremor. Yet despite its clinical success, conventional deep brain stimulation remains limited in its ability to address one of the disease’s most disabling symptoms: walking impairments.
Researchers from EPFL and Lausanne University Hospital (CHUV) have developed a new approach, published in Nature Medicine, that adapts DBS in real time to the patient’s mobility in everyday situations. Thanks to artificial intelligence, the system continuously interprets the patient’s activity and adjusts stimulation in real time, improving walking, climbing stairs and even the simple act of standing up.
13 years ago, I sat down with Doug Wolens to talk about a word almost no one was using: the singularity.
Doug was a lawyer who walked away from the courtroom to make films. His documentary, The Singularity, did something rare. It refused to cheerlead. It asked questions instead.
One thing he said has stayed with me ever since. Science is a means, not an end. It does not deliver a scientific destination. It delivers a humanistic one.
That distinction matters more now than it did in 2013.
Back then, machine intelligence surpassing human intelligence was a thought experiment. Today, it is a product roadmap. We used to argue about whether it would happen. Now we argue about what to do while it does.
But the sharpest question in Doug’s film was never about the machines. It was about us.
Osteoporosis is a silent disease where bone loss develops gradually before fractures occur. Current clinical screening recommendations mainly focus on older women and selected high-risk groups, leaving some men, younger adults, and individuals with normal body weight completely outside routine screening pathways.
To close this care gap, researchers from St. Paul’s Hospital and National Taiwan University have demonstrated how AI can leverage routine chest X-rays to detect asymptomatic bone loss, closing critical gaps in screening healthy Asian populations. Their paper is published in the journal npj Digital Medicine.
Strikingly, the study found that more than half of the confirmed abnormal bone-density cases occurred in people with a normal body mass index (BMI). This reveals a severe diagnostic blind spot in conventional, guideline-based screening. By relying strictly on traditional criteria, health care systems routinely overlook healthy-weight individuals, younger adults, and men who are secretly losing bone density but remain completely off the clinical radar.
By Chuck Brooks, president of Brooks Consulting International and one of Executive Mosaic’s GovCon Experts
We have now transitioned from the age of digital dangers to an era of complete systemic vulnerability. The data clearly demonstrates that cyber threats are no longer sporadic; they represent a persistent, sophisticated phenomenon. Hackers are now utilizing autonomous adversaries rather than merely sophisticated tools.
Recent industry data obtained in early 2026 indicates a vertical trajectory, revealing that global AI-driven cyber incidents have surged by an astonishing 72 percent year-over-year. A 72 percent surge is not just growth; it’s systemic acceleration.
Because glucosamine is widely available and frequently used by older adults to support joint health, the researchers wanted to determine whether it could influence Alzheimer’s disease and related dementias (ADRD).
Working with collaborators Yi Guo, Ph.D., and Jiang Bian, Ph.D., the team used artificial intelligence to analyze deidentified UF Health records collected between 2012 and 2024. They focused on patients diagnosed with either ADRD or mild cognitive impairment (MCI).
Among those patients, researchers found that glucosamine use was relatively common. A total of 1,896 patients with ADRD and 2,750 patients with MCI reported taking the supplement, representing about 8% of each group.